Literature DB >> 2393859

Seasonal change in the concentration of progesterone receptor in breast cancer.

I M Holdaway1, B H Mason, R J Marshall, L M Neave, R G Kay.   

Abstract

There are conflicting reports of seasonal changes in steroid hormone receptor levels in breast cancer tissue. Estrogen receptor and progesterone (PR) receptor levels from 1132 tumors were thus grouped according to month of initial tumor detection or month of tissue sampling/surgery. There was a significant circannual variation in the mean monthly PR receptor concentration in patients grouped according to month of tissue sampling/surgery with peak PR levels in April (late summer-early autumn) and nadir values in August and September (late winter-early spring). There was no significant cyclic variation in estrogen receptor values. A significant annual variation in tumor PR concentration was also seen when receptor levels from individual tumors were grouped according to month of initial tumor detection, with peak PR levels found in January and February. The time interval between tumor detection and biopsy/surgery was 3.3 +/- 5.3 months (mean +/- SD) which was close to the interval between the peak PR concentration expressed by month of tumor detection compared with month of tissue sampling for receptor assay. There was also a significant seasonal variation in the month of initial tumor detection, with peak detection occurring in December (summer). The close synchrony between month of maximum tumor detection and month of peak PR concentration suggests that seasonal changes in detection of breast cancer may in part relate to seasonal changes in hormone responsiveness within tumor tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393859

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Seasonal variations in the presentation and growth of thyroid cancer.

Authors:  L A Akslen; R B Sothern
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

2.  No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC.

Authors:  Beatriz Grandal; Ashwaq Aljehani; Elise Dumas; Eric Daoud; Floriane Jochum; Paul Gougis; Judicaël Hotton; Amélie Lemoine; Sophie Michel; Enora Laas; Marick Laé; Jean-Yves Pierga; Khaoula Alaoui Ismaili; Florence Lerebours; Fabien Reyal; Anne Sophie Hamy
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

3.  Association between the month of diagnosis and prognosis in breast carcinoma.

Authors:  H Joensuu; S Toikkanen
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.